1. Home
  2. AUPH vs HLIO Comparison

AUPH vs HLIO Comparison

Compare AUPH & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$16.73

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

HLIO

Helios Technologies Inc.

HOLD

Current Price

$68.10

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUPH
HLIO
Founded
1993
1970
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
AUPH
HLIO
Price
$16.73
$68.10
Analyst Decision
Buy
Strong Buy
Analyst Count
7
6
Target Price
$17.86
★ $94.67
AVG Volume (30 Days)
★ 737.0K
319.5K
Earning Date
11-03-2026
11-02-2026
Dividend Yield
N/A
★ 0.71%
EPS Growth
★ 5075.00
23.93
EPS
0.53
★ 1.25
Revenue
★ $283,055,000.00
$200,727,000.00
Revenue This Year
$15.83
$6.80
Revenue Next Year
$21.30
$6.00
P/E Ratio
★ $31.62
$54.42
Revenue Growth
★ 20.38
N/A
52 Week Low
$11.48
$49.00
52 Week High
$19.25
$95.05

Technical Indicators

Market Signals
Indicator
AUPH
HLIO
Relative Strength Index (RSI) 57.21 45.64
Support Level $15.61 $66.25
Resistance Level $17.02 $69.41
Average True Range (ATR) 0.40 1.80
MACD 0.05 0.09
Stochastic Oscillator 68.77 34.69

Price Performance

Historical Comparison
AUPH
HLIO

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About HLIO Helios Technologies Inc.

Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.

Share on Social Networks: